Literature DB >> 7448814

Influence of sex hormones on prostatic secretion protein, a major protein in rat prostate.

A Pousette, P Björk, K Carlström, B Forsgren, B Högberg, J A Gustafsson.   

Abstract

Prostatic secretion protein (PSP) or estramustine-binding protein is a major protein in rat ventral prostate. The amount of PSP was measured per mg of cytosolic protein at different ages and after castration or administration of sex hormones. The amount of PSP is relatively low before puberty (25 microgram/mg of protein) but increases at about 28 days of age to about 670 microgram/mg of protein and then decreases to a constant level of about 300 to 400 microgram/mg of protein, which is stable until at least 9 months of age. Following castration, the amount of PSP decreased relatively slowly, but 6 days after castration less than 20% of the original amount of PSP was detected. Treatment with testosterone propionate (1 mg/day) for 2 weeks (starting 2 weeks after castration) restored precastration levels of PSP. It is concluded that PSP is an androgen-sensitive protein, and it is suggested that PSP should be considered as a probe for estimation of androgenic action on the prostate. PSP is similar to the so-called prostatic binding protein as well as to prostatein, and it is quite possible that the three proteins represent one and the same entity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7448814

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Presence of oestrogen receptors on target cells and antiproliferative activity of estramustine phosphate: positive correlation for human tumours in vitro.

Authors:  J Pavelić; I Zgradić; K Pavelić
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Estramustine-binding protein in malignant glioma in rat.

Authors:  A E Karlsson; P Björk; A T Bergenheim; J Sandström; H Hedman; R Henriksson
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

3.  Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer.

Authors:  F Boccardo; A Decensi; D Guarneri; G Martorana; C Giberti; L Giuliani
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.

Authors:  E von Schoultz; D Lundblad; J Bergh; K Grankvist; R Henriksson
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.